# Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

> **NCT00418171** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 18239 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Ziprasidone
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00418171
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 18239 (ACTUAL)
- **Last updated:** 2009-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418171, "Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00418171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*